腹腔区域免疫特性:复杂性腹腔感染向腹腔脓毒症演进的关键机制与临床意义OA
Regional immunity of the peritoneal cavity in intra-abdominal sepsis:mechanisms and clinical implications
本文系统阐述了复杂性腹腔感染(IAI)及其导致腹腔脓毒症的临床与病生理特征,重点解析其与腹腔区域免疫特性的内在关联.腹腔脓毒症由复杂性IAI进展而来,是一种区别于其他解剖部位感染所致脓毒症的独特免疫病理过程,表现为起病迅速、病程进展快及病死率居高不下.其核心机制在于腹腔内由乳斑、腹腔驻留巨噬细胞、B1细胞及先天淋巴样细胞等构成的高度敏感、快速响应的区域性免疫防御体系.感染发生后,该免疫网络被迅速激活,在腹腔局部形成强烈炎症反应,以利于早期病原体的限制与清除.然而,当局部免疫防御失衡或感染控制失败时,腹腔相对封闭的解剖结构及其高度发达的血管与淋巴网络,反而会促使炎症反应持续放大,并快速向全身播散,驱动腹腔脓毒症的发生与进展,成为复杂性IAI进展为腹腔脓毒症并导致预后不良的关键病生理基础.聚焦腹腔区域免疫在感染后的动态重塑过程及其由局部向系统转化的关键机制,将有助于在现有治疗框架基础上,为早期风险识别、病程判断及靶向干预提供基于免疫发病机制的转化研究路径.
This review systematically delineates the clinical and pathophysiological features of complicated intra-abdominal infection(cIAI)and intra-abdominal sepsis(IAS),with a particular focus on their intrinsic association with the compartment-specific immune characteristics of the peritoneal cavity.IAS typically evolves from cIAI and represents a distinct immunopathological entity compared with sepsis originating from other anatomical sites,characterized by rapid onset,accelerated disease progression,and high mortality.The underlying basis of this process lies in the highly sensitive regional immune defense system of the peritoneal cavity,composed of specialized immune units including milky spots,peritoneal resident macrophages(PRM),B1 cells,and innate lymphoid cells(ILC).Following the onset of cIAI,this immune network is rapidly activated,generating an intense localized inflammatory response that facilitates early containment and clearance of invading pathogens.However,when local immune regulation becomes dysbalanced or effective pathogen control fails,the relatively confined anatomy of the peritoneal cavity,together with its dense vascular and lymphatic networks,instead promotes sustained inflammatory amplification and rapid systemic dissemination,thereby driving the development and progression of IAS.Future studies should therefore focus on elucidating the dynamic remodeling of peritoneal regional immunity after infection and the key mechanisms governing its transition from localized activation to systemic involvement.Such insights,built upon existing therapeutic frameworks,may provide a novel biological basis for early risk identification,disease course assessment,and mechanism-informed intervention strategies,ultimately contributing to improved clinical outcomes in patients with cIAI and IAS.
陈政霖;马涛
天津医科大学总医院普通外科,天津 300152天津医科大学总医院普通外科,天津 300152
腹腔感染区域免疫特性脓毒症乳斑腹腔驻留巨噬细胞B1细胞先天淋巴样细胞
intra-abdominal infectionregional immune characteristicsintra-abdominal sepsismilky spotsperitoneal resident macrophagesB1 cellsinnate lymphoid cells
《感染、炎症、修复》 2026 (1)
1-7,7
国家自然科学基金资助(NSFC82172122)
评论